Law360, New York (December 2, 2013, 5:07 PM EST) -- DNA tester 23andMe Inc. was hit with a proposed class action Wednesday, in which the company is accused of falsely advertising its saliva collection kit and personal genome service product as accurately providing health reports on more than 240 genetic medical conditions.
The Nov. 27 lawsuit followed the U.S. Food and Drug Administration's decision last week to order 23andMe — run by Anne Wojcicki, the wife of Google Inc. co-founder Sergey Brin — to halt sales of its genetic tests, saying the unapproved product could result in dangerous false positives or negatives.
Plaintiff Lisa Casey alleges that 23andMe's advertisements tout the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!